Belumosudil achieves clinical response in chronic graft-<i>versus</i>-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial

Letters to the Editor

Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial

Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, FL

Sanofi, Morristown, NJ

Sanofi, Cambridge, MA

Sanofi, Morristown, NJ

Hematopoietic Cell Transplant and Cellular Therapy Program, Mass General Brigham Cancer Institute, Boston, MA

Haematologica Early view Jul 23, 2026 https://doi.org/10.3324/haematol.2026.301043

Not available.

Early view : Letters to the Editor

DOI

Published

2026-07-23

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

Copyright & Usage

Online Views

187

PDF Downloads

84

No Data

PlumX